CADASIL and migraine: A narrative review

Michael K Liem1, Saskia A J Lesnik Oberstein, Jeroen van der Grond

  • 1Leiden University Medical Center, Netherlands. m.k.liem@lumc.nl

Insights

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), linked to NOTCH3 mutations, shows a higher prevalence of migraine with aura. This review explores how CADASIL may illuminate migraine pathophysiology.

Area of Science:

  • Neurology
  • Genetics
  • Vascular Neurology

Background:

  • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a genetic disorder caused by NOTCH3 gene mutations.
  • Clinical features include recurrent stroke, cognitive decline, psychiatric issues, and migraine, with a notably higher prevalence of migraine with aura in CADASIL patients compared to the general population.

Purpose of the Study:

  • To review existing literature on migraine in CADASIL.
  • To investigate potential pathophysiological mechanisms underlying the increased prevalence of migraine with aura in CADASIL.
  • To explore how studying CADASIL can enhance understanding of general migraine pathophysiology.

Main Methods:

  • This is a narrative review.
  • Literature search on migraine and CADASIL was conducted.
  • Focus on studies investigating the link between NOTCH3 mutations, cortical spreading depression (CSD), and migraine aura.

Main Results:

  • Migraine is more common in CADASIL patients, with a significantly higher proportion experiencing migraine with aura.
  • The exact mechanism for increased migraine aura prevalence in CADASIL remains unclear.
  • Hypothesized mechanisms include altered susceptibility or expression of cortical spreading depression (CSD), potential involvement of brainstem migraine areas, or the NOTCH3 mutation acting as a migraine aura susceptibility gene.

Conclusions:

  • CADASIL presents a unique model for studying migraine with aura.
  • Further research into CADASIL may reveal novel insights into the genetic and physiological underpinnings of migraine.
  • Understanding the role of NOTCH3 in migraine pathophysiology could lead to new therapeutic targets.